UPDATE: Agilent Licenses DNA Microarrays to Applied Biosystems

Jan 24, 2001

This article has been updated from a previous version

NEW YORK, Jan 24 - Agilent has licensed its custom in situ DNA microarrays to Applied Biosystems under a technology access agreement, the companies said Wednesday.

Applied Biosystems will use the microarrays for internal research and development only and did not gain a license to commercialize the Agilent arrays.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

When the Ailment You're Studying Becomes Personal

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

Irish Genomics Initiative Looks to Expand Into Scotland

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

Another Source of Data for 23andMe

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

This Week in PLOS

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.

Main menu